Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Cells
|
April 3, 2020
Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?
Klaus-Peter Künkele, Daniela Wesch, Hans-Heinrich Oberg, et al.
Iscience
|
April 3, 2023
Tumor microenvironment mimicking 3D models unveil the multifaceted effects of SMAC mimetics
Catarina Pinto, Ksenija Slavic-Obradovic, Daniela Fürweger, et al.
The Journal of Experimental Medicine
|
August 17, 2011
Loss of Roquin induces early death and immune deregulation but not autoimmunity
Arianna Bertossi, Martin Aichinger, Paola Sansonetti, et al.
Genes & Development
|
April 13, 2019
The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain <i>Cd4</i> silencing in cytotoxic T cells
Charles Ng, Martin Aichinger, Tung Nguyen, et al.
Nature Methods
|
October 18, 2017
CRISPR-UMI: single-cell lineage tracing of pooled CRISPR-Cas9 screens
Georg Michlits, Maria Hubmann, Szu-Hsien Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2022
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
Irmgard Hofmann, Anke Baum, Marco H Hofmann, et al.
Nature Communications
|
May 20, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Anna Skucha, Jessica Ebner, Johannes Schmöllerl, et al.
Nature
|
January 18, 2019
Human blood vessel organoids as a model of diabetic vasculopathy
Reiner A Wimmer, Alexandra Leopoldi, Martin Aichinger, et al.
Journal of Medicinal Chemistry
|
August 27, 2025
Discovery of Macrocyclic Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors that Demonstrate Potent Cellular Efficacy and In Vivo Activity in a Mouse Solid Tumor Xenograft Model
James C Tarr, Kyuok Jeon, Nagarathanam Veerasamy, et al.
Cell Reports. Medicine
|
August 26, 2025
Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models
Ksenija Slavic Obradovic, Florian Ebner, Artem V Artemov, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Cells
|
April 3, 2020
Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?
Klaus-Peter Künkele, Daniela Wesch, Hans-Heinrich Oberg, et al.
Iscience
|
April 3, 2023
Tumor microenvironment mimicking 3D models unveil the multifaceted effects of SMAC mimetics
Catarina Pinto, Ksenija Slavic-Obradovic, Daniela Fürweger, et al.
The Journal of Experimental Medicine
|
August 17, 2011
Loss of Roquin induces early death and immune deregulation but not autoimmunity
Arianna Bertossi, Martin Aichinger, Paola Sansonetti, et al.
Genes & Development
|
April 13, 2019
The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain <i>Cd4</i> silencing in cytotoxic T cells
Charles Ng, Martin Aichinger, Tung Nguyen, et al.
Nature Methods
|
October 18, 2017
CRISPR-UMI: single-cell lineage tracing of pooled CRISPR-Cas9 screens
Georg Michlits, Maria Hubmann, Szu-Hsien Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2022
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
Irmgard Hofmann, Anke Baum, Marco H Hofmann, et al.
Nature Communications
|
May 20, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Anna Skucha, Jessica Ebner, Johannes Schmöllerl, et al.
Nature
|
January 18, 2019
Human blood vessel organoids as a model of diabetic vasculopathy
Reiner A Wimmer, Alexandra Leopoldi, Martin Aichinger, et al.
Journal of Medicinal Chemistry
|
August 27, 2025
Discovery of Macrocyclic Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors that Demonstrate Potent Cellular Efficacy and In Vivo Activity in a Mouse Solid Tumor Xenograft Model
James C Tarr, Kyuok Jeon, Nagarathanam Veerasamy, et al.
Cell Reports. Medicine
|
August 26, 2025
Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models
Ksenija Slavic Obradovic, Florian Ebner, Artem V Artemov, et al.
Page
of 3